VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes
Xue Han, Zhuqi Huang, Guoxuan Liu, Yanan Liu, Weiqi Li, Jianing Zheng, Jie Tong, Mingyang He, Yurou Wu, Ze Li, Wu Luo, Qiaojuan Shi, Huazhong Ying, Guang Liang · 2026
Read VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes by Xue Han, Zhuqi Huang, Guoxuan Liu, Yanan Liu, Weiqi Li, Jianing Zheng, Jie Tong, Mingyang He, Yurou Wu, Ze Li, Wu Luo, Qiaojuan Shi, Huazhong Ying, Guang Liang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13181061.txt.
Description
Fifteen researchers in China trace a driver of diabetic heart damage in a 2026 paper. Diabetic cardiomyopathy weakens the heart muscle, and the enzymes that strip ubiquitin tags are suspects with unclear roles. One such enzyme, VCPIP1, ran high in diabetic hearts, mainly inside muscle cells.
Deleting it only in heart muscle eased damage in both type 1 and type 2 diabetes mouse models. Protein mapping showed the enzyme removes a specific tag from the gamma subunit of the energy sensor AMPK. That removal breaks the sensor's assembly, blocks its activation, and wrecks mitochondrial breathing. A mutant subunit copied the harm, pinning the pathway. The axis offers a drug target.
Catalog record
| CREATOR | Xue Han, Zhuqi Huang, Guoxuan Liu, Yanan Liu, Weiqi Li, Jianing Zheng, Jie Tong, Mingyang He, Yurou Wu, Ze Li, Wu Luo, Qiaojuan Shi, Huazhong Ying, Guang Liang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |